Your browser doesn't support javascript.
loading
Hepatoprotective effects of Tagetes lucida root extract in carbon tetrachloride-induced hepatotoxicity in Wistar albino rats through amelioration of oxidative stress.
El-Newary, Samah Ali; Ismail, Rasha Fouad; Shaffie, Nermeen Mohammed; Hendawy, Saber Fayez; Omer, Elsayed; Ahmed, Mahgoub Mohammed; ELsayed, Wael M.
Afiliação
  • El-Newary SA; Medicinal and Aromatic Plants Research Department, National Research Centre, Giza, Egypt.
  • Ismail RF; Medicinal and Aromatic Plants Research Department, National Research Centre, Giza, Egypt.
  • Shaffie NM; Pathology Department, Medical Researches Division, National Research Centre, Giza, Egypt.
  • Hendawy SF; Medicinal and Aromatic Plants Research Department, National Research Centre, Giza, Egypt.
  • Omer E; Medicinal and Aromatic Plants Research Department, National Research Centre, Giza, Egypt.
  • Ahmed MM; Molecular Drug Evaluation Department, National Organization for Drug Control and Research (NODCAR), Giza, Egypt.
  • ELsayed WM; Chemistry of Medicinal Plants Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Giza, Egypt.
Pharm Biol ; 59(1): 986-997, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34347571
CONTEXT: The roots of Tagetes lucida Cav. (Asteraceae) have antioxidant and antimicrobial properties. OBJECTIVE: This study aimed to examine the hepatoprotective effects of T. lucida roots ethanol extract (TLRE) using carbon tetrachloride (CCl4)-induced hepatotoxicity in rats. MATERIALS AND METHODS: The active ingredients of TLRE were identified by high-performance liquid chromatography, infra-red spectrum, and mass spectrometric procedures. Ninety rats were distributed into four main groups: positive, therapeutic, protective, and negative group. The therapeutic group was implemented using CCl4 (a single dose of 2 mL/kg) before TLRE or silymarin administration. Meanwhile, the protective group was implemented by administering CCl4 (a single dose of 2 mL/kg) after force-feeding TLRE or silymarin. Each therapeutic and protective group was divided into three subgroups: force-fed with saline, TLRE (500 mg/kg), and silymarin (25 mg/kg). The positive group was split into two subgroups that were force-fed TLRE and silymarin. Positive, therapeutic, and protective groups were compared to the negative group (untreated rats). CCl4, TLRE, and silymarin were orally administrated using a gastric tube. RESULTS: In the therapeutic and protective groups, TLRE significantly reduced liver enzymes, i.e., aspartate aminotransferase (12.47 and 6.29%), alanine aminotransferase (30.48 and 11.39%), alkaline phosphatase (17.28 and 15.90%), and cytochrome P450-2E1 (39.04 and 48.24%), and tumour necrosis factor-α (53.72 and 53.72%) in comparison with CCl4-induced hepatotoxicity controls. CONCLUSIONS: TLRE has a potent hepatoprotective effect with a good safety margin. After a repeated study on another type of small experimental animal, their offspring, and an experiment with a large animal, this study may lead to clinical trials.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Extratos Vegetais / Estresse Oxidativo / Tagetes / Doença Hepática Induzida por Substâncias e Drogas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Pharm Biol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Extratos Vegetais / Estresse Oxidativo / Tagetes / Doença Hepática Induzida por Substâncias e Drogas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Pharm Biol Ano de publicação: 2021 Tipo de documento: Article